East West Eye Institute has been acquired by NVISION Eye Centers
East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, has sold a majority interest to Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the USA.
EWEI’s seven clinics, two state-of-the-art surgery centers, aesthetic center and clinical research division are strategically located across Los Angeles, with more than 35 practice partners, associates or affiliated community physicians providing more than 70,000 clinic visits per year.
Nvision, based in Aliso Viejo, California, is an innovative leader in ophthalmology and is backed by the Ontario Teachers’ Pension Plan. This transaction allows Nvision, with a combined 70 practice and ASC locations across five states (California, Nevada, Oregon, Washington and Arizona), to broaden its existing operations. Dr. Alex Liu will be promoted to the role of chief executive officer of the EWEI subsidiary to facilitate EWEI’s integration and to continue driving Nvision’s growth in the Los Angeles market.
Oaklins’ team in Los Angeles acted as the sell-side advisor in this transaction.



Dr. Fred Kurata
CEO, East West Eye Institute
Talk to the deal team

Adam Abramowitz
Managing Director
Los Angeles, United StatesOaklins Intrepid
Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreSerenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.
Learn moreBiosynex has acquired Para’kito
Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.
Learn more